Female Health (FHCO) Receiving Somewhat Positive Press Coverage, AlphaOne Reports
News articles about Female Health (NASDAQ:FHCO) have been trending somewhat positive this week, according to Alpha One Sentiment. Alpha One, a division of Accern, identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Alpha One ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Female Health earned a daily sentiment score of 0.19 on Alpha One’s scale. Alpha One also assigned news articles about the company an impact score of 75 out of 100, meaning that recent media coverage is likely to have an effect on the company’s share price in the near future.
Here are some of the news articles that may have effected Alpha One’s rankings:
- FEMALE HEALTH CO : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (4-traders.com)
- BRIEF-Female Health director Bethune buys 10,000 shares of co’s common stock on May 15 (FHCO) (markets.businessinsider.com)
- O B. Parrish Purchases 20,000 Shares of Female Health Co (FHCO) Stock (americanbankingnews.com)
- Female Health Co (FHCO) Director Purchases $20,600.00 in Stock (americanbankingnews.com)
Shares of Female Health (NASDAQ:FHCO) traded up 1.94% on Friday, hitting $1.05. The stock had a trading volume of 18,400 shares. The company has a 50-day moving average of $1.00 and a 200-day moving average of $1.02. Female Health has a 52-week low of $0.72 and a 52-week high of $1.65. The company’s market cap is $32.53 million.
Female Health (NASDAQ:FHCO) last announced its earnings results on Tuesday, May 9th. The company reported ($0.06) earnings per share (EPS) for the quarter. Female Health had a negative net margin of 14.65% and a negative return on equity of 7.20%. The business had revenue of $2.41 million for the quarter. On average, equities analysts anticipate that Female Health will post $0.15 EPS for the current fiscal year.
In other Female Health news, Director Georges Makhoul bought 100,000 shares of the company’s stock in a transaction on Monday, March 20th. The stock was acquired at an average price of $1.05 per share, for a total transaction of $105,000.00. Following the completion of the transaction, the director now directly owns 189,444 shares of the company’s stock, valued at $198,916.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders have acquired 162,931 shares of company stock valued at $169,369 in the last 90 days. Company insiders own 9.80% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/05/20/female-health-fhco-receiving-somewhat-favorable-news-coverage-analysis-finds-updated.html.
Female Health Company Profile
The Female Health Company is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Stock Ratings for Female Health Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Female Health Co and related stocks with our FREE daily email newsletter.